Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 795

    1.

    Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy.

    Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, Kubicka S, Manns MP, Strassburg CP, Wedemeyer J.

    Gastroenterol Res Pract. 2009;2009:947014. Epub 2009 Nov 15.PMID: 19920868 [PubMed - in process]Related articlesFree article

    2.

    Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.

    Dieterich DT, Rizzetto M, Manns MP.

    J Viral Hepat. 2009 Dec;16(12):833-43.PMID: 19889142 [PubMed - in process]Related articles

    3.

    HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.

    Wiegand J, Meya S, Schlaphoff V, Manns MP, Mössner J, Wedemeyer H, Tillmann HL.

    J Viral Hepat. 2009 Nov 2. [Epub ahead of print]PMID: 19889141 [PubMed - as supplied by publisher]Related articles

    4.

    Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system.

    Wedemeyer J, Brangewitz M, Kubicka S, Jackobs S, Winkler M, Neipp M, Klempnauer J, Manns MP, Schneider AS.

    Gastrointest Endosc. 2009 Oct 29. [Epub ahead of print]PMID: 19879566 [PubMed - as supplied by publisher]Related articles

    5.

    Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.

    Pischke S, Suneetha P, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg C, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns M, Grummer B, Wedemeyer H.

    Liver Transpl. 2009 Oct 28. [Epub ahead of print]PMID: 19866448 [PubMed - as supplied by publisher]Related articles

    6.

    Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.

    Wang C, Heim A, Schlaphoff V, Suneetha PV, Stegmann KA, Jiang H, Krueger M, Fytili P, Schulz T, Cornberg M, Kandolf R, Manns MP, Bock CT, Wedemeyer H.

    J Med Virol. 2009 Dec;81(12):2079-88.PMID: 19856479 [PubMed - in process]Related articles

    7.

    Gilbert's syndrome and antiviral therapy of hepatitis C.

    Deterding K, Grüngreiff K, Lankisch TO, Potthoff A, Bahr MJ, Manns MP, Wedemeyer H, Strassburg CP.

    Ann Hepatol. 2009 Jul-Sep;8(3):246-50.PMID: 19841506 [PubMed - in process]Related articles

    8.

    Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.

    Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H; for HIDT-1 Study Group.

    Liver Int. 2009 Oct 15. [Epub ahead of print]PMID: 19840253 [PubMed - as supplied by publisher]Related articles

    9.

    Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.

    Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T.

    Hepatology. 2009 Nov;50(5):1638-45.PMID: 19821520 [PubMed - in process]Related articles

    10.

    Changes in Plasma Amino Acids During Extracorporeal Liver Support by Fractionated Plasma Separation and Adsorption.

    Rifai K, Das A, Rosenau J, Ernst T, Kretschmer U, Haller H, Fliser D, Manns MP.

    Artif Organs. 2009 Oct 10. [Epub ahead of print]PMID: 19817727 [PubMed - as supplied by publisher]Related articles

    11.

    Secretagogue stimulation enhances NBCe1 (electrogenic Na+/HCO3- cotransporter) surface expression in murine colonic crypts.

    Yu H, Riederer B, Stieger N, Boron WF, Shull GE, Manns MP, Seidler UE, Bachmann O.

    Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1223-31. Epub 2009 Sep 24.PMID: 19779011 [PubMed - in process]Related articles

    12.

    Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.

    Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, Manns MP, Tillmann HL.

    J Clin Virol. 2009 Nov;46(3):210-5. Epub 2009 Sep 17.PMID: 19766055 [PubMed - in process]Related articles

    13.

    Prof. Daniel Shouval.

    Manns MP.

    J Hepatol. 2009 Oct;51(4):620-2. No abstract available. PMID: 19760810 [PubMed - in process]Related articles

    14.

    Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection.

    Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ.

    Liver Int. 2009 Nov;29(10):1500-6. Epub 2009 Sep 3.PMID: 19732330 [PubMed - in process]Related articles

    15.

    Endoscopic retrograde cholangiopancreaticography prior to explorative laparotomy avoids unnecessary surgery in patients suspected for biliary atresia.

    Petersen C, Meier PN, Schneider A, Turowski C, Pfister ED, Manns MP, Ure BM, Wedemeyer J.

    J Hepatol. 2009 Dec;51(6):1055-60. Epub 2009 Aug 6.PMID: 19726099 [PubMed - in process]Related articles

    16.

    Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.

    Haridass D, Yuan Q, Becker PD, Cantz T, Iken M, Rothe M, Narain N, Bock M, Nörder M, Legrand N, Wedemeyer H, Weijer K, Spits H, Manns MP, Cai J, Deng H, Di Santo JP, Guzman CA, Ott M.

    Am J Pathol. 2009 Oct;175(4):1483-92. Epub 2009 Aug 28.PMID: 19717639 [PubMed - in process]Related articles

    17.

    The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.

    Schüngel S, Buitrago-Molina LE, Nalapareddy P, Lebofsky M, Manns MP, Jaeschke H, Gross A, Vogel A.

    Hepatology. 2009 Nov;50(5):1558-66.PMID: 19711425 [PubMed - in process]Related articles

    18.

    Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma.

    Zhao F, Obermann S, von Wasielewski R, Haile L, Manns MP, Korangy F, Greten TF.

    Immunology. 2009 Sep;128(1):141-9.PMID: 19689743 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma.

    Zhao F, Vermeer B, Lehmann U, Kreipe H, Manns MP, Korangy F, Greten TF.

    Immunology. 2009 Sep;128(1):134-40.PMID: 19689742 [PubMed - indexed for MEDLINE]Related articles

    20.

    SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: Identification of the native protein in human hepatic cell extract.

    Volkmann M, Luithle D, Zentgraf H, Schnölzer M, Fiedler S, Heid H, Schulze-Bergkamen A, Strassburg CP, Gehrke SG, Manns MP.

    J Autoimmun. 2009 Aug 13. [Epub ahead of print]PMID: 19683415 [PubMed - as supplied by publisher]Related articles

    21.

    Treatment of autoimmune hepatitis.

    Strassburg CP, Manns MP.

    Semin Liver Dis. 2009 Aug;29(3):273-85. Epub 2009 Aug 12. Review.PMID: 19676000 [PubMed - indexed for MEDLINE]Related articles

    22.

    Autoimmune hepatitis.

    Manns MP, Vergani D.

    Semin Liver Dis. 2009 Aug;29(3):239-40. Epub 2009 Aug 12. No abstract available. PMID: 19675996 [PubMed - indexed for MEDLINE]Related articles

    23.

    Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus.

    Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K.

    Artif Organs. 2009 Aug 7. [Epub ahead of print]PMID: 19663866 [PubMed - as supplied by publisher]Related articles

    24.

    The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.

    Nalapareddy P, Schüngel S, Hong JY, Manns MP, Jaeschke H, Vogel A.

    Am J Pathol. 2009 Sep;175(3):1077-85. Epub 2009 Aug 6.PMID: 19661444 [PubMed - in process]Related articles

    25.

    Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.

    Buitrago-Molina LE, Pothiraju D, Lamlé J, Marhenke S, Kossatz U, Breuhahn K, Manns MP, Malek N, Vogel A.

    Hepatology. 2009 Aug;50(2):500-9.PMID: 19642171 [PubMed - indexed for MEDLINE]Related articles

    26.

    The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.

    Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.

    Transpl Int. 2009 Oct;22(10):970-8. Epub 2009 Jul 10.PMID: 19619170 [PubMed - in process]Related articles

    27.

    Humanized mice for modeling human infectious disease: challenges, progress, and outlook.

    Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, Debarry J, de Jong Y, Deng H, Di Santo JP, Eisenbarth S, Eynon E, Flavell RA, Guzman CA, Huntington ND, Kremsdorf D, Manns MP, Manz MG, Mention JJ, Ott M, Rathinam C, Rice CM, Rongvaux A, Stevens S, Spits H, Strick-Marchand H, Takizawa H, van Lent AU, Wang C, Weijer K, Willinger T, Ziegler P.

    Cell Host Microbe. 2009 Jul 23;6(1):5-9. Review.PMID: 19616761 [PubMed - indexed for MEDLINE]Related articles

    28.

    Virological and clinical characteristics of delta hepatitis in Central Europe.

    Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H.

    J Viral Hepat. 2009 Dec;16(12):883-94. Epub 2009 Jun 28.PMID: 19566789 [PubMed - in process]Related articles

    29.

    Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.

    Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS.

    Vaccine. 2009 Aug 13;27(37):5142-51. Epub 2009 Jun 24.PMID: 19559112 [PubMed - indexed for MEDLINE]Related articles

    30.

    Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

    Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F.

    Hepatology. 2009 Sep;50(3):799-807.PMID: 19551844 [PubMed - indexed for MEDLINE]Related articles

    31.

    Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.

    Dintsios CM, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns MP, Krauth C.

    Eur J Gastroenterol Hepatol. 2009 Jun 22. [Epub ahead of print]PMID: 19550347 [PubMed - as supplied by publisher]Related articles

    32.

    Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.

    Vogel M, Deterding K, Wiegand J, Grüner NH, Baumgarten A, Jung MC, Manns MP, Wedemeyer H, Rockstroh JK; German Hepatitis Group; Hep-Net.

    Clin Infect Dis. 2009 Jul 15;49(2):317-9; author reply 319. No abstract available. PMID: 19538070 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Widespread and mostly unrecognized: chronic hepatitis B: the silent epidemic (interview by Maria Weiss)]

    Manns MP.

    MMW Fortschr Med. 2009 May 21;151(21):7. German. No abstract available. PMID: 19537625 [PubMed - indexed for MEDLINE]Related articles

    34.

    Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

    Siebert U, Sroczynski G, Aidelsburger P, Rossol S, Wasem J, Manns MP, McHutchison JG, Wong JB.

    Pharmacoeconomics. 2009;27(4):341-54. doi: 10.2165/00019053-200927040-00006.PMID: 19485429 [PubMed - indexed for MEDLINE]Related articles

    35.

    Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.

    Potthoff A, Witte T, Rifai K, Hoy L, Deterding K, Feyerabend S, Manns MP, Wedemeyer H.

    Scand J Gastroenterol. 2009;44(8):994-1003.PMID: 19462335 [PubMed - in process]Related articles

    36.

    p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.

    Gürlevik E, Woller N, Schache P, Malek NP, Wirth TC, Zender L, Manns MP, Kubicka S, Kühnel F.

    Nucleic Acids Res. 2009 Jul;37(12):e84. Epub 2009 May 14.PMID: 19443444 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.

    Klade CS, Kubitschke A, Stauber RE, Meyer MF, Zinke S, Wiegand J, Zauner W, Aslan N, Lehmann M, Cornberg M, Manns MP, Reisner P, Wedemeyer H.

    Vaccine. 2009 May 18;27(23):3099-108. Epub 2009 Mar 11.PMID: 19428924 [PubMed - indexed for MEDLINE]Related articles

    38.

    Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

    Heringlake S, Schütte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL.

    Z Gastroenterol. 2009 May;47(5):417-23. Epub 2009 May 5.PMID: 19418409 [PubMed - indexed for MEDLINE]Related articles

    39.

    [Liver transplantation: indications and results]

    Strassburg CP, Manns MP.

    Internist (Berl). 2009 May;50(5):550-60. Review. German. PMID: 19387600 [PubMed - indexed for MEDLINE]Related articles

    40.

    [Transplantation medicine 2009]

    Strassburg CP, Manns MP.

    Internist (Berl). 2009 May;50(5):521-2. German. No abstract available. PMID: 19381609 [PubMed - indexed for MEDLINE]Related articles

    41.

    Transient autoimmune hepatitis induced by a thymoma.

    Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, Dietze O, Hutter J, Manns MP, Datz C.

    Am J Gastroenterol. 2009 May;104(5):1332-4. Epub 2009 Apr 7. No abstract available. PMID: 19352338 [PubMed - indexed for MEDLINE]Related articles

    42.

    Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.

    Lankisch TO, Behrens G, Ehmer U, Möbius U, Rockstroh J, Wehmeier M, Kalthoff S, Freiberg N, Manns MP, Schmidt RE, Strassburg CP.

    J Hepatol. 2009 May;50(5):1010-8. Epub 2009 Mar 5.PMID: 19303655 [PubMed - indexed for MEDLINE]Related articles

    43.

    Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system.

    Kielstein JT, Hesse G, Bahr MJ, Tsikas D, Terkamp C, Martens-Lobenhoffer J, Manns MP, Haller H, Panning B, Bode-Böger SM, Gebel M.

    Crit Care Med. 2009 Apr;37(4):1483-5.PMID: 19242353 [PubMed - indexed for MEDLINE]Related articles

    44.

    Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.

    Mederacke I, Wedemeyer H, Manns MP.

    Curr Opin Investig Drugs. 2009 Feb;10(2):181-9. Review.PMID: 19197796 [PubMed - indexed for MEDLINE]Related articles

    45.

    Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.

    Ramakrishna E, Woller N, Mundt B, Knocke S, Gürlevik E, Saborowski M, Malek N, Manns MP, Wirth T, Kühnel F, Kubicka S.

    Cancer Res. 2009 Feb 15;69(4):1448-58. Epub 2009 Feb 3.PMID: 19190348 [PubMed - indexed for MEDLINE]Related articles

    46.

    Natural history: the importance of viral load, liver damage and HCC.

    Wursthorn K, Manns MP, Wedemeyer H.

    Best Pract Res Clin Gastroenterol. 2008;22(6):1063-79. Review.PMID: 19187867 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Sorafenib for the treatment of HCC--the beginning of a new era in the treatment of HCC]

    Greten TF, Manns MP, Malek N.

    Z Gastroenterol. 2009 Jan;47(1):55-60. Epub 2009 Jan 20. Review. German. PMID: 19156592 [PubMed - indexed for MEDLINE]Related articles

    48.

    Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.

    Suneetha PV, Schlaphoff V, Wang C, Stegmann KA, Fytili P, Sarin SK, Manns MP, Cornberg M, Wedemeyer H.

    J Immunol Methods. 2009 Mar 15;342(1-2):33-48. Epub 2009 Jan 9.PMID: 19135447 [PubMed - indexed for MEDLINE]Related articles

    49.

    cAMP-dependent and cholinergic regulation of the electrogenic intestinal/pancreatic Na+/HCO3- cotransporter pNBC1 in human embryonic kidney (HEK293) cells.

    Bachmann O, Franke K, Yu H, Riederer B, Li HC, Soleimani M, Manns MP, Seidler U.

    BMC Cell Biol. 2008 Dec 22;9:70.PMID: 19102757 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.

    Jeffe F, Stegmann KA, Broelsch F, Manns MP, Cornberg M, Wedemeyer H.

    J Leukoc Biol. 2009 Mar;85(3):452-61. Epub 2008 Dec 26.PMID: 19095736 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...